The effects of nomegestrol acetate on carbohydrate metabolism were inv
estigated in 20 premenopausal women presenting with menstrual disturba
nces. The progestogen was administered from day 5 to day 24 of the cyc
le, over six consecutive cycles, at a dosage (5 mg/d) known to inhibit
ovulation. A 3 hour oral glucose tolerance test (OGTT) was performed
prior to the hormonal intake and at 3 months and 6 months of therapy.
Blood glucose and insulin were measured before and for 3 hours after a
75 g glucose load, and the glucose and insulin areas under the curves
(AUC) were calculated. The fasting glycosylated hemoglobin and fructo
samine were also determined. Treatment did not induce any significant
changes in plasma glucose or insulin glucose values during the oral gl
ucose tolerance test, in glucose and insulin areas under the curves or
in glycosylated protein levels. Two women with impaired glucose toler
ance were not worsened during therapy. These data suggest that nomeges
trol acetate is free from adverse effects on glucose tolerance after 6
months treatment.